Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Manufacturing
Novo charts $1B-plus Brazilian production expansion for GLP-1s
Looking to boost GLP-1 capacity in Latin America’s biggest country, Novo is charting a $1.09 billion expansion at its manufacturing plant in Brazil.
Fraiser Kansteiner
Apr 8, 2025 9:40am
Rhythm preps filings in rare obesity disease after trial win
Apr 7, 2025 9:52am
Novo Nordisk offers cheaper Wegovy for all cash-paying patients
Mar 24, 2025 10:15am
Lilly backs study to improve disease representation in media
Mar 20, 2025 3:35pm
Viking taps CordenPharma in $150M obesity drug production deal
Mar 11, 2025 10:25am
Lilly starts banking stockpile of oral GLP-1 asset
Feb 24, 2025 10:47am
